news
News
-
-
news
Bespak & H&T Presspart announce availability of GMP pilot line for low GWP pMDIs
-
news
Bespak takes a seat on the Board at IPAC
-
news
Bespak reaches key milestone in the expansion of its manufacturing capacity, with further expansion plans underway to meet global customer demand for climate friendly inhalers
-
news
DevPro Biopharma and Bespak announce completion of early feasibility study for new ground-breaking albuterol inhaler
-
news
Bespak and H&T Presspart enter into collaboration agreement to advance transition to low GWP propellants in pMDIs
-
news
Bespak and Medicines Evaluation Unit collaborate to accelerate clinical trials on climate-friendly inhalers
-
news
Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs
-
news
Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
-
news
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
-
news
Recipharm makes senior appointments as transition to low global warming potential propellants in pressurised Metered Dose Inhalers gains pace
-
news
Honeywell And Recipharm To Speed Development Of Inhalers With A Near-Zero Global Warming Potential Propellant